banner

ImVacS - the Immunotherapeutics and Vaccine Summit 2014
- ImVacS -2014年免疫疗法及疫苗学会 -
2014年8月11 - 14日 美国,马萨诸塞州,波士顿,长码头万豪酒店

ImVacS高峰会是邀集来自世界各地,参与癌症免疫疗法用疫苗的研究开发的人士,来探索患者的治疗基础──免疫学的未开拓领域的四个集中性学会。

第9届年度学会Novel Vaccines的第1部将以『佐剂、TLR、DNA疫苗』为主题。第2部则要探索『新兴疫苗技术』。第2届年度学会Immunomodulatory Therapeutic Antibodies for Cancer将验证这些新兴药物开发所用的模式及工具的发展趋势,此外首次召开的Combination Cancer Immunotherapy将以与其他治疗模式并用的这些抗体计划的应用为焦点。Target Discovery for T Cell Therapy研讨会将邀集带动学术界及产业界的研究人员们,共同讨论如何发现治疗细胞用的适当标的及抗原,及立证其正当性的方法。

会议Track


主题简报:
Norman Baylor未来的疫苗佐剂相关的法律预测

Norman W. Baylor, Ph.D., President and CEO, Biologics Consulting Group, Inc.

主题简报:
Bolyn Hubby为了解决新兴威胁及全球供给问题的合成基因学

Bolyn Hubby, Ph.D., Senior Director, Head, Vaccine and Phage R&D, Synthetic Genomics Vaccines, Inc.

主题简报:
Michael Postow透过新免疫调整策略来检验癌症

Michael A. Postow, M.D., Assistant Attending Physician, Melanoma and Immunotherapeutics Service, Memorial Sloan-Kettering Cancer Center

主题简报:
Omid Hamid2014年ASCO学会的最新趋势:免疫调整并用疗法的临床实验

Omid Hamid, M.D., Director, Melanoma Center, Angeles Clinic and Research Institute

8月12日 - 13日

Combination Cancer Immunotherapy

Each year, ImVacS brings vaccine professionals together from around the world to discuss the crucial issues surrounding vaccine development. Along with presenting a snapshot of where vaccines stand today, the meeting also provides an important venue for networking, information exchange, and establishing collaborations.

The "Novel Vaccines" meeting explores how vaccine development is being innovated in order to create more efficacious vaccines, such as using Systems Biology or Reverse Vaccinology. The use of adjuvants – their safety and mode of action – will also be discussed, as will DNA vaccines, Toll-Like Receptors, and novel modes of delivery. In addition, how improved vaccines are targeting infectious diseases will be addressed and updated.


Choose your language
Chinese
Japanese
Korean
English

Catalog

赞助商

媒体合作夥伴


Attendee Icon

2013年的参加者


 
产业会议汇总历
生物科技相关国际会议

生物科技相关国际会议

免费电子邮件通知服务
免费电子邮件通知服务